Free Trial

Kiora Pharmaceuticals (KPRX) Institutional Ownership

Kiora Pharmaceuticals logo
$2.44 +0.04 (+1.45%)
As of 02:30 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Kiora Pharmaceuticals (NASDAQ:KPRX)

Current
Institutional Ownership
Percentage
76.97%
Number of
Institutional Buyers
(last 12 months)
5
Total
Institutional Inflows
(last 12 months)
$470.70K
Number of
Institutional Sellers
(last 12 months)
4
Total
Institutional Outflows
(last 12 months)
$440.16K
Get KPRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Kiora Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

KPRX Institutional Buying and Selling by Quarter

Kiora Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/13/2026Nantahala Capital Management LLC106,156$209K0.0%-32.1%2.886%
2/13/2026Alyeska Investment Group L.P.76,904$152K0.0%N/A2.090%
2/12/2026DRW Securities LLC110,282$217K0.0%+199.2%2.997%
2/12/2026Renaissance Technologies LLC21,200$42K0.0%+71.0%0.576%
11/17/2025Nantahala Capital Management LLC156,427$435K0.0%-25.9%4.253%
11/17/2025Citadel Advisors LLC44,573$125K0.0%N/A1.212%
11/14/2025Two Sigma Investments LP11,984$33K0.0%N/A0.326%
8/13/2025Stonepine Capital Management LLC178,000$513K0.5%-11.3%5.190%
7/29/2025 AIGH Capital Management LLC216,345$623K0.3%-14.7%7.117%
5/16/2025ADAR1 Capital Management LLC194,665$586K0.1%-2.8%6.395%
2/14/2025Rosalind Advisors Inc.250,555$827K0.4%-2.0%8.352%
2/13/2025ADAR1 Capital Management LLC200,221$661K0.1%+1.9%6.674%
2/11/2025Rosalind Advisors Inc.250,555$827K0.4%-2.0%8.352%
8/21/2024Stonepine Capital Management LLC200,000$840K0.8%N/A6.856%
8/20/2024Nantahala Capital Management LLC211,110$887K0.1%-88.9%7.237%
8/7/2024AIGH Capital Management LLC255,561$1.07M0.3%-88.9%8.761%
7/12/2024Rosalind Advisors Inc.255,555$1.07M0.8%-88.9%8.752%
4/25/2024Rosalind Advisors Inc.2,300,000$1.62M1.5%N/A8.759%


KPRX Institutional Ownership - Frequently Asked Questions

During the previous two years, 10 institutional investors and hedge funds held shares of Kiora Pharmaceuticals. The most heavily invested institutionals were Rosalind Advisors Inc. ($827K), AIGH Capital Management LLC ($623K), ADAR1 Capital Management LLC ($586K), Stonepine Capital Management LLC ($513K), DRW Securities LLC ($217K), Nantahala Capital Management LLC ($209K), and Alyeska Investment Group L.P. ($152K).Learn more on Kiora Pharmaceuticals' institutional investors.

76.97% of Kiora Pharmaceuticals' stock is owned by institutional investors. Learn more on KPRX's institutional investor holdings.

The following institutional investors have purchased Kiora Pharmaceuticals' stock in the last 24 months: Stonepine Capital Management LLC ($200K), Alyeska Investment Group L.P. ($76.90K), DRW Securities LLC ($73.42K), Citadel Advisors LLC ($44.57K), Two Sigma Investments LP ($11.98K), Renaissance Technologies LLC ($8.80K), and ADAR1 Capital Management LLC ($3.67K).

Institutional investors have bought a total of 215,678 shares in the last 24 months. This purchase volume represents approximately $470.70K in transactions.

The following institutional investors have sold Kiora Pharmaceuticals stock in the last 24 months: Nantahala Capital Management LLC ($104.95K), AIGH Capital Management LLC ($37.21K), Stonepine Capital Management LLC ($22.65K), and ADAR1 Capital Management LLC ($5.56K).

Institutional investors have sold a total of 170,367 shares in the last 24 months. This volume of shares sold represents approximately $440.16K in transactions.



This page (NASDAQ:KPRX) was last updated on 5/12/2026 by MarketBeat.com Staff.
From Our Partners